Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 03, 2024 |
referred to insurance |
Oct 04, 2023 |
print number 2393b |
Oct 04, 2023 |
amend (t) and recommit to insurance |
May 25, 2023 |
print number 2393a |
May 25, 2023 |
amend and recommit to insurance |
Jan 20, 2023 |
referred to insurance |
Senate Bill S2393B
2023-2024 Legislative Session
Sponsored By
(D, WF) 31st Senate District
Current Bill Status - In Senate Committee Insurance Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Bill Amendments
co-Sponsors
(D, WF) 47th Senate District
2023-S2393 - Details
2023-S2393 - Sponsor Memo
BILL NUMBER: S2393 SPONSOR: JACKSON TITLE OF BILL: An act to amend the insurance law, in relation to requiring individual and small group insurance carriers and group and blanket accident and health carriers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale PURPOSE: To ensure patients benefit from substantial discounts that exist within the prescription drug supply chain. SUMMARY OF PROVISIONS: Section 1 adds a new subparagraph (C) to subsection (e) of Section 3231 of the Insurance Law to require individual and small group carriers to certify that at least a majority (greater than 50%) of prescription drug rebates are provided to patients at the point of sale.
2023-S2393 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 2393 2023-2024 Regular Sessions I N S E N A T E January 20, 2023 ___________ Introduced by Sen. JACKSON -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance AN ACT to amend the insurance law, in relation to requiring individual and small group insurance carriers and group and blanket accident and health carriers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Paragraph 1 of subsection (e) of section 3231 of the insur- ance law, as added by chapter 501 of the laws of 1992, is amended by adding a new subparagraph (C) to read as follows: (C) AN INSURER SHALL ANNUALLY CERTIFY TO THE DEPARTMENT THAT, DURING THE PRIOR BENEFIT YEAR, THE INSURER MADE AVAILABLE TO ENROLLEES AT THE POINT OF SALE AT LEAST A MAJORITY (I.E., GREATER THAN FIFTY PERCENT) OF THE REBATES RECEIVED BY SUCH INSURER OR ANY THIRD PARTY ADMINISTERING PRESCRIPTION DRUG BENEFITS ON BEHALF OF SUCH INSURER. (I) FOR PURPOSES OF THIS PARAGRAPH, "REBATE" MEANS: (1) NEGOTIATED PRICE CONCESSIONS INCLUDING BUT NOT LIMITED TO BASE REBATES AND REASONABLE ESTIMATES OF ANY PRICE PROTECTION REBATES AND PERFORMANCE-BASED REBATES THAT MAY ACCRUE DIRECTLY OR INDIRECTLY TO THE ISSUER DURING THE COVERAGE YEAR FROM A MANUFACTURER, DISPENSING PHARMA- CY, OR OTHER PARTY TO THE TRANSACTION, AND (2) REASONABLE ESTIMATES OF ANY FEES AND OTHER ADMINISTRATIVE COSTS THAT ARE PASSED THROUGH TO THE ISSUER AND SERVE TO REDUCE THE ISSUER'S PRESCRIPTION DRUG LIABILITIES FOR THE COVERAGE YEAR. (II) IN PROVIDING THE CERTIFICATION REQUIRED UNDER THIS SUBPARAGRAPH, AN ISSUER SHALL SHARE INFORMATION REGARDING THE ACTUAL AMOUNT OF REBATES THE ISSUER RECEIVED ON A PRODUCT-, MANUFACTURER- OR PHARMACY-SPECIFIC BASIS WITH THE DEPARTMENT AND THE AMOUNT THAT WAS PASSED THROUGH TO CONSUMERS. ANY INFORMATION SHARED UNDER THIS SUBPARAGRAPH SHALL BE CONFIDENTIAL AND NOT SUBJECT TO DISCLOSURE BY THE DEPARTMENT. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD05427-01-3
co-Sponsors
(D, WF) 47th Senate District
2023-S2393A - Details
2023-S2393A - Sponsor Memo
BILL NUMBER: S2393A SPONSOR: JACKSON TITLE OF BILL: An act to amend the insurance law, in relation to requiring individual and small group insurance carriers and group and blanket accident and health carriers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale PURPOSE: To ensure patients benefit from substantial discounts that exist within the prescription drug supply chain. SUMMARY OF PROVISIONS: Section 1 adds a new subparagraph (C) to subsection (e) of Section 3231 of the Insurance Law to require individual and small group carriers to certify that at least a majority (greater than 50%) of prescription drug rebates are provided to patients at the point of sale.
2023-S2393A - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 2393--A 2023-2024 Regular Sessions I N S E N A T E January 20, 2023 ___________ Introduced by Sens. JACKSON, HOYLMAN-SIGAL -- read twice and ordered printed, and when printed to be committed to the Committee on Insur- ance -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the insurance law, in relation to requiring individual and small group insurance carriers and group and blanket accident and health carriers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Paragraph 1 of subsection (e) of section 3231 of the insur- ance law is amended by adding a new subparagraph (C) to read as follows: (C) AN INSURER SHALL ANNUALLY CERTIFY TO THE DEPARTMENT THAT, DURING THE PRIOR BENEFIT YEAR, THE INSURER MADE AVAILABLE TO ENROLLEES AT THE POINT OF SALE AT LEAST A MAJORITY (I.E., GREATER THAN FIFTY PERCENT) OF THE REBATES RECEIVED BY SUCH INSURER OR ANY THIRD PARTY ADMINISTERING PRESCRIPTION DRUG BENEFITS ON BEHALF OF SUCH INSURER. (I) FOR PURPOSES OF THIS PARAGRAPH, "REBATE" MEANS: (1) NEGOTIATED PRICE CONCESSIONS INCLUDING BUT NOT LIMITED TO BASE REBATES AND REASONABLE ESTIMATES OF ANY PRICE PROTECTION REBATES AND PERFORMANCE-BASED REBATES THAT MAY ACCRUE DIRECTLY OR INDIRECTLY TO THE ISSUER DURING THE COVERAGE YEAR FROM A MANUFACTURER, DISPENSING PHARMA- CY, OR OTHER PARTY TO THE TRANSACTION, AND (2) REASONABLE ESTIMATES OF ANY FEES AND OTHER ADMINISTRATIVE COSTS THAT ARE PASSED THROUGH TO THE ISSUER AND SERVE TO REDUCE THE ISSUER'S PRESCRIPTION DRUG LIABILITIES FOR THE COVERAGE YEAR. (II) IN PROVIDING THE CERTIFICATION REQUIRED UNDER THIS SUBPARAGRAPH, AN ISSUER SHALL NOT PUBLISH OR OTHERWISE REVEAL INFORMATION REGARDING THE ACTUAL AMOUNT OF REBATES THE ISSUER RECEIVED ON A PRODUCT-, MANUFAC- TURER- OR PHARMACY-SPECIFIC BASIS. SUCH INFORMATION IS PROTECTED AS A TRADE SECRET, IS NOT A PUBLIC RECORD AS DEFINED IN THE PUBLIC OFFICERS EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD05427-03-3
co-Sponsors
(D) 30th Senate District
(D) 34th Senate District
(D, WF) 47th Senate District
2023-S2393B (ACTIVE) - Details
2023-S2393B (ACTIVE) - Sponsor Memo
BILL NUMBER: S2393B SPONSOR: JACKSON TITLE OF BILL: An act to amend the insurance law and the public health law, in relation to requiring certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale PURPOSE: To ensure patients benefit from substantial discounts that exist within the prescription drug supply chain. SUMMARY OF PROVISIONS: Section 1 adds a new Section 3245 to Article 32 of the Insurance Law, defining "Defined cost sharing," "Insurer," "Price Protection Rebate," and "Rebate;" requiring individual and small group carriers to certify that at least a majority (greater than 85%) of prescription drug rebates are provided to patients at the point of sale.
2023-S2393B (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 2393--B 2023-2024 Regular Sessions I N S E N A T E January 20, 2023 ___________ Introduced by Sens. JACKSON, HOYLMAN-SIGAL -- read twice and ordered printed, and when printed to be committed to the Committee on Insur- ance -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the insurance law and the public health law, in relation to requiring certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The insurance law is amended by adding a new section 3246 to read as follows: § 3246. ENSURING FAIRNESS IN CERTAIN COST SHARING. (A) AS USED IN THIS SECTION, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS: (1) "DEFINED COST SHARING" MEANS A DEDUCTIBLE PAYMENT OR COINSURANCE AMOUNT IMPOSED ON AN ENROLLEE FOR A COVERED PRESCRIPTION DRUG UNDER THE ENROLLEE'S HEALTH PLAN. (2) "INSURER" MEANS ANY HEALTH INSURANCE ISSUER THAT IS SUBJECT TO STATE LAW REGULATING INSURANCE AND OFFERS HEALTH INSURANCE COVERAGE, AS DEFINED IN 42 U.S.C. § 300GG-91, OR ANY STATE OR LOCAL GOVERNMENTAL EMPLOYER PLAN. (3) "PRICE PROTECTION REBATE" MEANS A NEGOTIATED PRICE CONCESSION THAT ACCRUES DIRECTLY OR INDIRECTLY TO THE INSURER, OR OTHER PARTY ON BEHALF OF THE INSURER, IN THE EVENT OF AN INCREASE IN THE WHOLESALE ACQUISITION COST OF A DRUG ABOVE A SPECIFIED THRESHOLD. (4) "REBATE" MEANS: (A) NEGOTIATED PRICE CONCESSIONS INCLUDING BUT NOT LIMITED TO BASE PRICE CONCESSIONS, WHETHER DESCRIBED AS A REBATE OR OTHERWISE, AND REASONABLE ESTIMATES OF ANY PRICE PROTECTION REBATES AND PERFORMANCE- EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD05427-04-3
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.